Health Alert:

Starting Feb. 29, masking is optional but encouraged in UPMC medical facilities and most patient care settings.

Brexucabtagene autoleucel (Tecartus)

About This Treatment

Brexucabtagene autoleucel is used to treat cancer. It is made using your own T-cells, a type of white blood cell. Your T-cells will be collected via leukapheresis, a procedure that circulates your blood through a machine and removes some of your T-cells. Your collected T-cells are then genetically modified to recognize your cancer cells and attack them. Brexucabtagene autoleucel contains your modified T-cells and is given to you through the vein (IV).

View the fact sheet about Brexucabtagene autoleucel (PDF).